98 related articles for article (PubMed ID: 2151065)
1. Teicoplanin therapy in children: a review.
Bassetti D; Cruciani M
Scand J Infect Dis Suppl; 1990; 72():35-7. PubMed ID: 2151065
[TBL] [Abstract][Full Text] [Related]
2. Teicoplanin for therapy of gram-positive infections in neutropenic patients.
Verhagen C; De Pauw BE
Int J Clin Pharmacol Res; 1987; 7(6):491-8. PubMed ID: 2964418
[TBL] [Abstract][Full Text] [Related]
3. [The use of teicoplanin in neutropenic patients: values and limits].
Espinouse D; Chomarat M
Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):552-6. PubMed ID: 2143573
[TBL] [Abstract][Full Text] [Related]
4. Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients.
Lemerle S; de La Rocque F; Lamy R; Fremaux A; Bernaudin F; Lobut JB; Reinert P
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():113-6. PubMed ID: 2965122
[TBL] [Abstract][Full Text] [Related]
5. [Teicoplanin and Gram-positive coccus infections. Results of a multicenter study on 66 cases].
Dureux JB; Canton P; Chavanet P; Chippaux C; Dupeyron JP; Estavoyer JM; Giorgi C; Jaeger A; Jehl F; Kazmierzack A
Pathol Biol (Paris); 1987 May; 35(5):511-5. PubMed ID: 2956564
[TBL] [Abstract][Full Text] [Related]
6. Therapy of serious gram-positive infections with teicoplanin.
Davies AJ; Stone JM; Synott M
Drugs Exp Clin Res; 1989; 15(1):29-31. PubMed ID: 2526010
[TBL] [Abstract][Full Text] [Related]
7. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
[TBL] [Abstract][Full Text] [Related]
8. The role of gram-positive therapy in the neutropenic patient.
Menichetti F; Del Favero A
J Antimicrob Chemother; 1991 Apr; 27 Suppl B():51-60. PubMed ID: 1829077
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis, cost and effectiveness of therapy of infections caused by gram-positive organisms in neutropenic children.
Schaison GS; Decroly FC
J Antimicrob Chemother; 1991 Apr; 27 Suppl B():61-7. PubMed ID: 1829078
[TBL] [Abstract][Full Text] [Related]
10. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
Vázquez L; Encinas MP; Morín LS; Vilches P; Gutiérrez N; García-Sanz R; Caballero D; Hurlé AD
Haematologica; 1999 Mar; 84(3):231-6. PubMed ID: 10189388
[TBL] [Abstract][Full Text] [Related]
11. [Imipenem combined with teicoplanin or vancomycin in the initial empirical treatment of febrile neutropenia. Analysis of the primary response and of a global sequential strategy in 126 episodes].
Figuera A; Tomás JF; Hernández L; Jiménez ML; Peñarrubia MJ; del Rey MC; Arranz R; Cámara R; López-Lorenzo JL; Fernández-Rañada JM
Rev Clin Esp; 1996 Aug; 196(8):515-22. PubMed ID: 8984537
[TBL] [Abstract][Full Text] [Related]
12. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
[TBL] [Abstract][Full Text] [Related]
13. Comparison of efficacy and safety of teicoplanin in gram-positive infections: a multicentre study.
Lang E; Schäfer V; Schaaf B; Dennhardt R
Scand J Infect Dis Suppl; 1990; 72():54-60. PubMed ID: 2151067
[TBL] [Abstract][Full Text] [Related]
14. Teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin in the treatment of febrile neutropenic patients.
Kelsey SM; Weinhardt B; Collins PW; Newland AC
Eur J Clin Microbiol Infect Dis; 1992 Jun; 11(6):509-14. PubMed ID: 1388120
[TBL] [Abstract][Full Text] [Related]
15. A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients.
Kelsey SM; Collins PW; Delord C; Weinhard B; Newland AC
Br J Haematol; 1990 Dec; 76 Suppl 2():10-3. PubMed ID: 2149044
[TBL] [Abstract][Full Text] [Related]
16. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
17. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.
Oguz A; Karadeniz C; Citak EC; Cil V; Eldes N
Pediatr Hematol Oncol; 2006; 23(3):245-53. PubMed ID: 16517540
[TBL] [Abstract][Full Text] [Related]
18. The use of aminoglycosides in neutropenic patients.
Cometta A; Glauser MP
Schweiz Med Wochenschr Suppl; 1996; 76():21S-27S. PubMed ID: 8677415
[TBL] [Abstract][Full Text] [Related]
19. Therapy of infections related to intraperitoneal catheters in patients with ovarian cancer.
Meunier F; van der Auwera P; Aoun M; Piccart M; Sculier JP
Scand J Infect Dis Suppl; 1990; 72():26-8. PubMed ID: 2151063
[TBL] [Abstract][Full Text] [Related]
20. [Microbiological-clinical study on the efficacy of a new antibiotic: teicoplanin].
Martinetto P; Gariglio M; Malcangi A; Cavallo GP
G Batteriol Virol Immunol; 1985; 78(1-6):86-94. PubMed ID: 2943627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
